Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline-Reference-Cited by-同舟云学术

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

Published:2006 Issue:10 Volume:21 Page:1716-1721
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

deMarcaida J. Antonelle,Schwid Steven R.,White William B.,Blindauer Karen,Fahn Stanley,Kieburtz Karl,Stern Matthew,Shoulson Ira, ,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference20 articles.

1. HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS

2. . Interactions of monoamine oxidase inhibitors, amines and foodstuffs. In: , , , editors. Advances in pharmacology and chemotherapy. New York: Academic; 1970. p 185–239.

3. DEPRENYL IN PARKINSON'S DISEASE

4. (-)Deprenyl in the Treatment of Parkinsonʼs Disease

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease;Biomedicine & Pharmacotherapy;2024-07

2. Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system;Scientific Reports;2023-11-06

3. Two weeks dose range-finding and four weeks repeated dose oral toxicity study of a novel reversible monoamine oxidase B inhibitor KDS2010 in cynomolgus monkeys;Toxicological Research;2023-06-24

4. Human genome or human microbiome genes: Which one is more important for human health and intellectual abilities?;Microbiome Metabolome Brain Vagus Nerve Circuit in Disease and Recovery;2023

5. A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease;Journal of Neural Transmission;2022-02-02